Home | Business News | Browse by Publication | P | Pharma Marketletter

CytoDyn/ Timeway JV gets support.

Publication: Pharma Marketletter
Publication Date: 06-MAR-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: CytoDyn/ Timeway JV gets support.(Timeway International, joint venture)(Brief Article)

Article Excerpt
USA-based CytoDyn, a specialist in the extension of targeted immune therapies beyond their current use as treatments for cancer and auto-immune diseases to treat immunologically-mediated infectious diseases, says that its proposed joint venture with China's Timeway International has received support from US and Hong Kong-based investors. The anticipated collaboration...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Chiesi's Russian subsidiary and Dutch JV.(Chiesi Farmaceutici S.p.A. a..., March 06, 2006
NicOx sees 2005 revenues of 6.6 M euros.(Brief Article), March 06, 2006
Takeda most respected pharma company in Japan for 7th year.(Takeda Che..., March 06, 2006
Headlines 25 years ago this week....(Eli Lilly and Co. to pay $500, 00..., March 06, 2006
Stock Commentary - Europe - week to Feb 27, 2006.(Brief Article), March 06, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.